DEFINITIVE PROXY STATEMENT

Company

Protalix BioTherapeutics, Inc.

Filed

September 18, 2009

Period of Report

November 9, 2009

Accession Number

0000950123-09-043950

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →